1. Home
  2. Clinical Practice
  3. Cardiology
advertisement

ATTRibute-CM: Insights from ESC HF

Fontana
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
  • Overview

    In this video brief recorded following ESC Heart Failure (ESC HF), Dr. Marianna Fontana discusses findings related to outpatient worsening heart failure in transthyretin amyloid cardiomyopathy (ATTR-CM). The discussion explores the clinical significance of worsening heart failure events occurring outside the hospital setting and their relationship to disease progression and patient outcomes in ATTR-CM. Dr. Fontana reviews key data presented at ESC HF and provides perspective on how these findings may influence patient monitoring, risk assessment, and therapeutic decision-making in clinical practice. The program also highlights the importance of incorporating outpatient worsening heart failure events into the broader evaluation of disease burden and progression in ATTR-CM

  • Provider

    Global Learning Collaborative 

    Global Learning Collaborative (GLC) designs and executes continuing education rooted in evidence-based medicine, clinical need, knowledge gap analysis, and careful consideration of learner feedback. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. GLC’s methodology is founded on a commitment to continuing medical education and the innovative assessment of its effects on clinical practice. Our goal is clear—to develop and deliver the best education in the most impactful manner and to verify its results with progressive outcomes research. 

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.  

     Reproduction Prohibited  

    Reproduction of this material is not permitted without written permission from the copyright owner.  

Recommended
Details
Presenters
  • Overview

    In this video brief recorded following ESC Heart Failure (ESC HF), Dr. Marianna Fontana discusses findings related to outpatient worsening heart failure in transthyretin amyloid cardiomyopathy (ATTR-CM). The discussion explores the clinical significance of worsening heart failure events occurring outside the hospital setting and their relationship to disease progression and patient outcomes in ATTR-CM. Dr. Fontana reviews key data presented at ESC HF and provides perspective on how these findings may influence patient monitoring, risk assessment, and therapeutic decision-making in clinical practice. The program also highlights the importance of incorporating outpatient worsening heart failure events into the broader evaluation of disease burden and progression in ATTR-CM

  • Provider

    Global Learning Collaborative 

    Global Learning Collaborative (GLC) designs and executes continuing education rooted in evidence-based medicine, clinical need, knowledge gap analysis, and careful consideration of learner feedback. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. GLC’s methodology is founded on a commitment to continuing medical education and the innovative assessment of its effects on clinical practice. Our goal is clear—to develop and deliver the best education in the most impactful manner and to verify its results with progressive outcomes research. 

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.  

     Reproduction Prohibited  

    Reproduction of this material is not permitted without written permission from the copyright owner.  

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free